During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Localization of activated natural killer (A-NK) cells in the microvasculature of growing tumors is the result of recognition of the intracellular and vascular cell-adhesion molecules ICAM-1 and VCAM-1 on the tumor endothelium, mediated by lymphocyte function-associated protein LFA-1 and vascular lymphocyte function-associated protein VLA-4. In vitro and in vivo studies of A-NK cell adhesion to endothelial cells showed that vascular endothelial growth factor (VEGF) promotes adhesion, whereas basic fibroblast growth factor (bFGF) inhibits adhesion through the regulation of these molecules on tumor vasculature. Thus, some angiogenic factors may facilitate lymphocyte recognition of angiogenic vessels, whereas others may provide such vessels with a mechanism that protects them from cytotoxic lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Angiogenic molecules present in the TME, such as VEGF (FIG. 1), can control the trafficking of immune cells to the tumour by altering the expression of adhesion molecules, including the integrin ligands intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion protein 1 (VCAM1), on endothelial cells (ECs) and immune cells10,14,15”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [14]
Citations
Cites
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Self-citationDefinition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Busch, H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00015 · Cited by 1,205
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Leukocyte adhesion to endothelium in inflammation
Osborn, L. (1990) · Cell · doi:10.1016/0092-8674(90)90230-c · Cited by 865
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., & Polverini, P. J. (1995) · Nature · doi:10.1038/376517a0 · Cited by 600
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.
de Fougerolles, A. R., Stacker, S. A., Schwarting, R., & Springer, T. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.1.253 · Cited by 495
Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., & Jain, R. K. (1994) · PubMed · Cited by 463
Self-citation
Research works printed but not linked: 2
- Wu, N.Z., Klitzman, B., Dodge, R. & Dewhirst, M.W. iminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 52, 4265–4268 (1992).
- Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. & Jain, R. uantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149, 59–71 (1996).
Cited by
Items 101–200 of 482
Zittermann, S. I., & Issekutz, A. C. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050479 · Cited by 171
VEGF function in vascular pathogenesis
Ng, Y., Krilleke, D., & Shima, D. T. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.008 · Cited by 169
Carmeliet, P., & Collen, D. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_7 · Cited by 167
Inagi, R., Miyata, T., Yamamoto, T., Suzuki, D., Urakami, K.-I., Saito, A., van Ypersele de Strihou, C., & Kurokawa, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01642-7 · Cited by 165
Imaging angiogenesis and the microenvironment
FUKUMURA, D., & JAIN, R. K. (2008) · APMIS · doi:10.1111/j.1600-0463.2008.01148.x · Cited by 162
Self-citationMougel, A., Terme, M., & Tanchot, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00467 · Cited by 161
Cellular mechanisms of blood-retinal barrier dysfunction in macular edema
Vinores, S. A., Derevjanik, N. L., Ozaki, H., Okamoto, N., & Campochiaro, P. A. (1999) · Documenta Ophthalmologica · doi:10.1023/a:1002136712070 · Cited by 161
Hellebrekers, D. M. E. I., Castermans, K., Viré, E., Dings, R. P. M., Hoebers, N. T. H., Mayo, K. H., oude Egbrink, M. G. A., Molema, G., Fuks, F., van Engeland, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1609 · Cited by 150
The Rationale and Future Potential of Angiogenesis Inhibitors in Neoplasia
Gasparini, G. (1999) · Drugs · doi:10.2165/00003495-199958010-00003 · Cited by 160
Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12
Kanegane, C., Sgadari, C., Kanegane, H., Teruya-Feldstein, J., Yao, L., Gupta, G., Farber, J. M., Liao, F., Liu, L., & Tosato, G. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.384 · Cited by 151
Kuenen, B. C., Levi, M. M., Meijers, J. C. M., Kakkar, A. K., van Hinsbergh, V. W. M., Kostense, P. J., Pinedo, H. M., & Hoekman, K. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000030186.66672.36 · Cited by 159
Koukourakis, M. I., Giatromanolaki, A. N., Thorpe, P. E., Brekken, R. A., Sivridis, E., Kakolyris, S., Georgoulias, V., Gatter, K. C., & Harris, A. L. (2000) · PubMed · Cited by 159
Sun, X., Kanwar, J. R., Leung, E. Y., Lehnert, K., Wang, D., & Krissansen, G. W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301388 · Cited by 158
Angiogenesis and Endothelial Cell Repair in Renal Disease and Allograft Rejection
Reinders, M. E. J., Rabelink, T. J., & Briscoe, D. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121250 · Cited by 157
Calcinotto, A., Grioni, M., Jachetti, E., Curnis, F., Mondino, A., Parmiani, G., Corti, A., & Bellone, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101877 · Cited by 140
Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization
Sakurai, E., Taguchi, H., Anand, A., Ambati, B. K., Gragoudas, E. S., Miller, J. W., Adamis, A. P., & Ambati, J. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1246 · Cited by 134
Ma, W., Wang, Y., Zhang, R., Yang, F., Zhang, D., Huang, M., Zhang, L., Dorsey, J. F., Binder, Z. A., O’Rourke, D. M., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00147-8 · Cited by 143
Ehrlich, R., Harris, A., Ciulla, T. A., Kheradiya, N., Winston, D. M., & Wirostko, B. M. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2008.01501.x · Cited by 143
“VEGFs possess pro-inflammatory properties that mediate chemotaxis and increase adhesion of leucocytes (Melder et al. 1996).”
BackgroundBagley, R. G., Walter-Yohrling, J., Cao, X., Weber, W. D., Simons, B., Cook, B. P., Chartrand, S., Wang, C., Madden, S. L., & Teicher, B. A. (2003) · PubMed · Cited by 143
Chen, X., Lin, J., Kanekura, T., Su, J., Lin, W., Xie, H., Wu, Y., Li, J., Chen, M., & Chang, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1536 · Cited by 134
Shen, W. Y., Yu, M. J. T., Barry, C. J., Constable, I. J., & Rakoczy, P. E. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.9.1063 · Cited by 140
Aberrant vascular architecture in tumors and its importance in drug-based therapies
Munn, L. L. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02686-2 · Cited by 139
Self-citationAngiogenesis in hematologic malignancies
Moehler, T. M., Ho, A. D., Goldschmidt, H., & Barlogie, B. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00135-x · Cited by 136
McGirt, M. J., Lynch, J., Blessing, R., Warner, D. S., Friedman, A. H., & Laskowitz, D. T. (2002) · Neurosurgery · doi:10.1097/00006123-200211000-00005 · Cited by 135
Serum Soluble Vascular Cell Adhesion Molecule-1: Role as a Surrogate Marker of Angiogenesis
Byrne, G. J., Ghellal, A., Iddon, J., Blann, A. D., Venizelos, V., Kumar, S., Howell, A., & Bundred, N. J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1329 · Cited by 134
Funk, M., Schmidinger, G., Maár, N., Bolz, M., Benesch, T., Zlabinger, G. J., & Schmidt-Erfurth, U. M. (2010) · Retina · doi:10.1097/iae.0b013e3181e095c0 · Cited by 133
Kariyazono, H., Ohno, T., Khajoee, V., Ihara, K., Kusuhara, K., Kinukawa, N., Mizuno, Y., & Hara, T. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000145280.26284.b9 · Cited by 132
Ruggeri, B., Singh, J., Gingrich, D. E., Angeles, T. S., Albom, M. S., Yang, S., Chang, H., Robinson, C., Hunter, K., Dobrzański, P., et al. (2003) · PubMed · Cited by 131
Chang, Y. S., Munn, L. L., Hillsley, M., Dull, R. O., Yuan, J., Lakshminarayanan, S., Gardner, T. W., Jain, R. K., & Tarbell, J. M. (2000) · Microvascular Research · doi:10.1006/mvre.1999.2225 · Cited by 130
Self-citationIntegrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors
Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., & Varner, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2704 · Cited by 127
Vascular development and disorders: Molecular analysis and pathogenic insights
Carmeliet, P., & Collen, D. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00936.x · Cited by 125
Uchida, S., Shimada, Y., Watanabe, G., Tanaka, H., Shibagaki, I., Miyahara, T., Ishigami, S., & Imamura, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.281 · Cited by 114
Hernández, C., Burgos, R., Cantón, A., García‐Arumí, J., Segura, R., & Simó, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.516 · Cited by 121
Oak, M. H., Bedoui, J. E., Madeira, S. V. F., Chalupský, K., & Schini‐Kerth, V. B. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706843 · Cited by 121
Tsuzuki, Y., Carreira, C. M., Bockhorn, M., Xu, L., Jain, R. K., & Fukumura, D. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780357 · Cited by 120
Self-citationStoll, B. R., Migliorini, C., Kadambi, A., Munn, L. L., & Jain, R. K. (2003) · Blood · doi:10.1182/blood-2003-02-0365 · Cited by 120
Self-citationJain, R. K., & Munn, L. L. (2000) · Nature Medicine · doi:10.1038/72212 · Cited by 118
Self-citationJain, R. K., Finn, A. V., Kolodgie, F. D., Gold, H. K., & Virmani, R. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0979 · Cited by 117
Self-citationCorticosteroids in posterior segment disease: an update on new delivery systems and new indications
Ciulla, T. A., Walker, J. D., Fong, D. S., & Criswell, M. H. (2004) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000120711.35941.76 · Cited by 117
Stefanik, D. F., Fellows, W. K., Rizkalla, L. R., Rizkalla, W., Stefanik, P. P., DeLeo, A. B., & Welch, W. C. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1013329832067 · Cited by 115
Anti-angiogenesis: making the tumor vulnerable to the immune system
Griffioen, A. W. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0524-3 · Cited by 114
Ren, S., Xiong, X., You, H., Shen, J., & Zhou, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.689132 · Cited by 114
“VEGF can reduce the expression of adhesion molecules critical for T cell infiltration, such as integrin ligand vascular cell adhesion protein 1 (VCAM1) and intercellular adhesion molecule 1 (ICAM1), on immune cells and endothelial cells (ECs) (45).”
BackgroundLinking tumour angiogenesis and tumour immunity
Kabir, A. U., Subramanian, M., Kwon, Y., & Choi, K. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01211-z · Cited by 111
Kadambi, A., Carreira, C. M., Yun, C., Padera, T. P., Dolmans, D. E. J. G. J., Carmeliet, P., Fukumura, D., & Jain, R. K. (2001) · PubMed · Cited by 110
Self-citationSaeed, A., Park, R., & Sun, W. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01034-0 · Cited by 109
Lee, C. Y. S., David, T., & Nishime, M. (2007) · Journal of Oral Implantology · doi:10.1563/1548-1336(2007)33[371:uoppit]2.0.co;2 · Cited by 106
Spector, J. A., Mehrara, B. J., Greenwald, J. A., Saadeh, P. B., Steinbrech, D. S., Bouletreau, P. J., Smith, L. P., & Longaker, M. T. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c72 · Cited by 104
Baar, J., Silverman, P., Lyons, J. A., Fu, P., Abdul‐Karim, F. W., Ziats, N. P., Wasman, J. K., Hartman, P. H., Jesberger, J. A., Dumadag, L., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2917 · Cited by 103
Stimulation of tumor growth by human soluble intercellular adhesion molecule-1.
Gho, Y. S., Kim, P. N., Li, H. C., Elkin, M., & Kleinman, H. K. (2001) · PubMed · Cited by 103
Krizanac-Bengez, L., Mayberg, M. R., & Janigro, D. (2004) · Neurological Research · doi:10.1179/016164104x3789 · Cited by 90
Role of the tumor stroma in resistance to anti-angiogenic therapy
Huijbers, E. J. M., van Beijnum, J. R., Thijssen, V. L., Sabrkhany, S., Nowak-Sliwinska, P. M., & Griffioen, A. W. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.02.002 · Cited by 105
“An important mechanism underlying this phenomenon s the suppression of endothelial adhesion molecules, such as ntercellular adhesion molecules (ICAMs), vascular cell adhesion olecules (VCAMs) and the family of selectins (Melder et al., 1996; riffioen et al., 1996a,b; Cedervall et al., 2015; Lanitis et al., 2015).”
BackgroundQian, C., Liu, C., Liu, W., Zhou, R., & Zhao, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1291530 · Cited by 101
Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune Evasion
Lin, K.-Y., Lu, D., Hung, C.-F., Peng, S., Huang, L., Jie, C., Murillo, F., Rowley, J., Tsai, Y.-C., He, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3014 · Cited by 94
Salvén, P., Teerenhovi, L. M., & Joensuu, H. (1999) · Blood · doi:10.1182/blood.v94.10.3334.422k18_3334_3339 · Cited by 100
Bazán‐Peregrino, M., Arvanitis, C., Rifai, B., Seymour, L. W., & Coussios, C. C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.086 · Cited by 99
The malignant clone and the bone-marrow environment
Podar, K., Richardson, P. G. G., Hideshima, T., Chauhan, D., & Anderson, K. C. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2007.08.002 · Cited by 98
Transformation of the microvascular system during multistage tumorigenesis
Ryschich, E., Schmidt, J., Hämmerling, G. J., Klar, E., & Ganss, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10074 · Cited by 87
Effect of rhPDGF-BB Delivery on Mediators of Periodontal Wound Repair
Cooke, J. W., Sarment, D. P., Whitesman, L. A., Miller, S. E., Jin, Q., Lynch, S. E., & Giannobile, W. V. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.1441 · Cited by 96
Oak, M., Chataigneau, M., Keravis, T. M., Chataigneau, T., Beretz, A., Andriantsitohaina, R., Stoclet, J., Chang, S.-J., & Schini‐Kerth, V. B. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000070101.70534.38 · Cited by 90
Modulation of Natural Killer Cell Anti-Tumor Reactivity by Platelets
Placke, T., Kopp, H., & Salih, H. R. (2011) · Journal of Innate Immunity · doi:10.1159/000323936 · Cited by 89
Bockhorn, M., Tsuzuki, Y., Xu, L., Frilling, A., Broelsch, C. E., & Fukumura, D. (2003) · PubMed · Cited by 89
Brkovic, A., & Sirois, M. G. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21124 · Cited by 89
Angiogenesis inhibitors overcome tumor induced endothelial cell anergy
Griffioen, A. W., Damen, C. A., Mayo, K. H., Barendsz-Janson, A. F., Martinotti, S., Blijham, G. H., & Groenewegen, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<315::aid-ijc23>3.0.co;2-l · Cited by 83
Biomarkers as outcome predictors in subarachnoid hemorrhage – a systematic review
Hong, C. M., Tosun, Ç., Kurland, D. B., Gerzanich, V., Schreibman, D. L., & Simard, J. M. (2014) · Biomarkers · doi:10.3109/1354750x.2014.881418 · Cited by 86
Understanding barriers to drug delivery: high resolution in vivo imaging is key.
Jain, R. K. (1999) · PubMed · Cited by 86
Self-citationRamana, K. V., Bhatnagar, A., & Sk, S. (2004) · The FASEB Journal · doi:10.1096/fj.04-1650com · Cited by 85
Fisher, D. T., Chen, Q., Appenheimer, M. M., Skitzki, J. J., Wang, W., Odunsi, K. O., & Evans, S. S. (2006) · Immunological Investigations · doi:10.1080/08820130600745430 · Cited by 84
Müller, A., Hermanns, M. I., Cronen, C., & Kirkpatrick, C. J. (2002) · Experimental and Molecular Pathology · doi:10.1006/exmp.2002.2446 · Cited by 83
Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent
Kazi, A. S., Lotfi, S., Goncharova, E. A., Tliba, O., Amrani, Y., Krymskaya, V. P., & Lazaar, A. L. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00130.2003 · Cited by 82
Baeten, C. I. M., Castermans, K., Hillen, H. F. P., & Griffioen, A. W. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.08.005 · Cited by 81
Cao, Z. A., Daniel, D., & Hanahan, D. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-11 · Cited by 81
Tumor angiogenesis factors reduce leukocyte adhesion in vivo
Tromp, S. C., oude Egbrink, M. G. A., Dings, R. P. M., van Velzen, S., Slaaf, D. W., Hillen, H. F. P., Tangelder, G. J., Reneman, R. S., & Griffioen, A. W. (2000) · International Immunology · doi:10.1093/intimm/12.5.671 · Cited by 79
Wang, P., Fang, X., Yin, T., Tian, H., Yu, J., & Teng, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.628124 · Cited by 80
“The excessive activation of VEGF-VEGFR pathways can directly inhibit the trafficking of immune cells to the tumor by inhibiting upregulation of the expression of intercellular adhesion molecule-1(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) (11, 29).”
BackgroundClinical significance of angiogenic factors in breast cancer
Locopo, N., Fanelli, M., & Gasparini, G. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006175504673 · Cited by 79
Dings, R. P. M., Vang, K. B., Castermans, K., Popescu, F. E., Zhang, Y., Egbrink, M. G. A. O., Mescher, M. F., Farrar, M. A., Griffioen, A. W., & Mayo, K. H. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2443 · Cited by 78
Angiogenesis by gene therapy: a new horizon for myocardial revascularization?
Lewis, B. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00170-3 · Cited by 73
Reinders, M. E. J., Fang, J. C.-T., Wong, W., Ganz, P., & Briscoe, D. M. (2003) · Transplantation · doi:10.1097/01.tp.0000071363.55007.d0 · Cited by 75
Boulday, G., Hašková, Z., Reinders, M. E. J., Pal, S., & Briscoe, D. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3098 · Cited by 75
Pharmacotherapy for diabetic retinopathy
Comer, G. M., & Ciulla, T. A. (2004) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000143685.60479.3b · Cited by 71
Spyridopoulos, I., Luedemann, C., Chen, D., Kearney, M., Chen, D., Murohara, T., Principe, N., Isner, J. M., & Losordo, D. W. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000020006.89055.11 · Cited by 74
Macrophages and angiogenesis in rheumatic diseases
Maruotti, N., Annese, T., Cantatore, F. P., & Ribatti, D. (2013) · Vascular Cell · doi:10.1186/2045-824x-5-11 · Cited by 72
Tsutsumi-Miyahara, C. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.036392 · Cited by 69
Angiogenesis in hematologic malignancies
Moehler, T. M., Neben, K., Ho, A. D., & Goldschmidt, H. (2001) · Annals of Hematology · doi:10.1007/s00277-001-0398-3 · Cited by 71
“[82] Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL,”
BackgroundRole of endothelial cell survival and death signals in angiogenesis
Nor, J. E., & Polverini, P. J. (1999) · Angiogenesis · doi:10.1023/a:1009053411094 · Cited by 71
McLeskey, S. W., Tobias, C. A., Vezza, P. R., Filie, A. C., Kern, F. G., & Hanfelt, J. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65713-6 · Cited by 70
Immune Effects of Bevacizumab: Killing Two Birds with One Stone
Elamin, Y. Y., Rafee, S., Toomey, S., & Hennessy, B. T. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0160-8 · Cited by 68
Vitreous Mediators in Retinal Hypoxic Diseases
dell’Omo, R., Semeraro, F., Bamonte, G., Cifariello, F., Romano, M. R., & Costagliola, C. (2013) · Mediators of Inflammation · doi:10.1155/2013/935301 · Cited by 68
Cerebrovascular adaptations to chronic hypoxia in the growth restricted lamb
Castillo‐Melendez, M., Yawno, T., Allison, B. J., Jenkin, G., Wallace, E. M., & Miller, S. L. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.01.004 · Cited by 61
Plastic Surgical Perspectives on Vascular Endothelial Growth Factor as Gene Therapy for Angiogenesis
Taub, P. J., Silver, L., & Weinberg, H. (2000) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200003000-00031 · Cited by 67
Role of bone marrow-derived cells in tumor angiogenesis and treatment
Jain, R. K., & Duda, D. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00138-7 · Cited by 67
Self-citationNowak-Sliwinska, P. M., van Beijnum, J. R., Griffioen, C. J., Huinen, Z. R., Sopesens, N. G., Schulz, R., Jenkins, S. V., Dings, R. P. M., Groenendijk, F. H., Huijbers, E. J. M., et al. (2022) · Angiogenesis · doi:10.1007/s10456-022-09863-4 · Cited by 66
Jayne, D. G., Perry, S., Morrison, E. E., Farmery, S. M., & Guillou, P. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1068 · Cited by 66
“They share similar properties with endothelial cells, a express the adhesion molecules ICAM-1, VCAM-1 and PECA 1 (Klein et al, 1995) which facilitate lymphocyte trafficking int the peritoneal cavity.”
BackgroundTao, X., Zhang, R., Du, R., Yu, T., Yang, H., Li, J., Wang, Y., Liu, Q., Zuo, S., Wang, X., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212414 · Cited by 65
“Itga4/VCAM1 binding is essential for NK cell adhesion and transmigration across the endothelium (Allavena et al., 1996; Melder et al., 1996).”
Gündoğan, F. Ç., Yolcu, Ü., Akay, F., İlhan, A., Özge, G., & Uzun, S. (2016) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.322.8496 · Cited by 64
Tumors resurrect an embryonic vascular program to escape immunity
Huijbers, E. J. M., Khan, K. A., Kerbel, R. S., & Griffioen, A. W. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm6388 · Cited by 64
Schultz, V., Suflita, M., Liu, X.-Y., Zhang, X., Yu, Y.-L., Li, L.-Y., Green, D. E., Xu, Y.-M., Zhang, F.-M., DeAngelis, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761585 · Cited by 42
Ma, L., Luo, L., Qiao, H., Dong, X., Pan, S., Jiang, H., Krissansen, G. W., & Sun, X. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.031 · Cited by 63
“Vasostatin inhibits endothelial cell proliferation and neovascularization [39], and may prevent angiogenesis-related inhibition of leukocyte binding to the vascular endothelium which is a prerequisite for leukocyte infiltration [40–42].”
BackgroundDual Role of Vascular Endothelial Growth Factor in Experimental Obliterative Bronchiolitis
Krebs, R., Tikkanen, J., Nykänen, A. I., Wood, J. M., Jeltsch, M., Ylä‐Herttuala, S., Koskinen, P., & Lemström, K. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1001oc · Cited by 62
Park, S., Kang, S., Chen, X., Kim, E. J., Kim, J., Kim, N., Kim, J., & Jin, M. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.004 · Cited by 62
Watanabe, M., McCormick, K. L., Völker, K., Ortaldo, J. R., Wigginton, J. M., Brunda, M. J., Wiltrout, R. H., & Fogler, W. E. (1997) · Europe PMC (PubMed Central) · Cited by 62
Metadata
- Authors
- Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., & Jain, R. K.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Venue
- Nature Medicine
- Published
- 1996-09
- Volume
- 2
- Issue
- 9
- Pages
- 992-997
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W304295984
- Cited by
- 451
- References
- 39
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 16 · 2021: 13 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 16 · 2013: 10 · 2012: 9
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32ca061631-01a2)
- National Cancer Institute (F32-CA 61631, R35CA056591, R35-CA-56591)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- natural killer cells, tumor endothelium, angiogenesis, vascular endothelial growth factor, basic fibroblast growth factor, cell adhesion, ICAM-1, VCAM-1, LFA-1, VLA-4, tumor vasculature, cytotoxic lymphocytes
- MeSH terms
- Animals, Cell Adhesion, Endothelium, Vascular, Humans, Lymphokines, Neoplasms, Experimental, Neovascularization, Pathologic, Tumor Cells, Cultured, Killer Cells, Lymphokine-Activated, Lymphocyte Function-Associated Antigen-1, Fibroblast Growth Factor 2, Endothelial Growth Factors, Mice, SCID, Intercellular Adhesion Molecule-1, P-Selectin, Vascular Cell Adhesion Molecule-1, E-Selectin, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.